APP and Alzheimer disease: We present data, for the first time, describing no global alterations in the proportion of AD-susceptible NF-labeled pyramidal neurons or AD-resistant calretinin-positive interneurons co-localized with the H3K4me3, H3K27ac and H3K27me3 histone marks across a time course in APP/PS1 and wild-type mice.